Oligosaccharyltransferase (OST) is a key enzyme of the N-glycosylation pathway, where it catalyzes the transfer of a glycan from a lipid-linked oligosaccharide (LLO) to an acceptor asparagine within the conserved sequon N-X-T/S. A previous structure of a ternary complex of bacterial single subunit OST, PglB, bound to a non-hydrolyzable LLO analog and a wild type acceptor peptide showed how both substrates bind and how an external loop (EL5) of the enzyme provided specific substrate-binding contacts. However, there was a relatively large separation of the substrates at the active site. Here we present the X-ray structure of PglB bound to a reactive LLO analog and an inhibitory peptide, revealing previously unobserved interactions in the active site. We found that the atoms forming the Nglycosidic bond (C-1 of the GlcNAc moiety of LLO and the -NH 2 group of the peptide) are closer than in the previous structure, suggesting that we have captured a conformation closer to the transition state of the reaction. We find that the distance between the divalent metal ion and the glycosidic oxygen of LLO is now 4 Å, suggesting that the metal stabilizes the leaving group of the nucleophilic substitution reaction. Further, the carboxylate group of a conserved aspartate of PglB mediates an interaction network between the reducing-end sugar of the LLO, the asparagine side chain of the acceptor peptide, and a bound divalent metal ion. The interactions identified in this novel state are likely to be relevant in the catalytic mechanisms of all OSTs.
provided key contacts to bound acceptor peptide. Engagement and disengagement of EL5 appeared essential for substrate binding and product release 19, 23 . Despite the available structural data, the exact mechanism of glycan transfer is not fully understood. For example, details of how the substrates interact and how the amido group of the acceptor asparagine is activated, are lacking. Specifically, the previously solved ternary complex structure revealed an arrangement of bound substrates that was evidently not very close to the transition state given that the distance between the atoms that would form the glycosidic bond was ~6 Å. Here we present the X-ray structure of PglB in complex with an inhibitory peptide and a synthetic reactive LLO analog. The structure captures a new intermediate of the glycosylation reaction where the substrates are significantly closer, identifying new contacts with conserved residues in the catalytic site. The new structural evidence reveals previously unknown interactions between PglB, LLO, acceptor peptide and the bound divalent metal ion.
Results
Strategy to trap a distinct ternary complex. Two strategies can in principle be pursued to trap ternary complex states of OST (Fig. 1 ). The first, which was the basis of the previously published structure 19 , was to co-crystallize PglB with wild type peptide (DQNAT(pNO 2 -F)) and a non-hydrolyzable, phosphonate-containing LLO analog (ωZZZ-PPCH 2 -GlcNAc). DQNATF is an optimal acceptor sequon for C. jejuni PglB and the phosphonate-containing LLO analog was identified as a competitive inhibitor ( Fig. 1) 14, 19, 24 . In the resulting ternary complex structure we found that the phosphonopyrophosphate group was not coordinated by the catalytic Mn 2+ ion and that the substrates were distantly located (~6 Å apart). We hypothesized that this gap was due to the use of a phosphonopyrophosphate rather than a pyrophosphate group and that using a reactive LLO might reveal a bound state closer to the transition state of the reaction. We therefore pursued a second strategy to form a ternary complex by incubating PglB with a functionally competent, synthetic LLO analog and an inhibitory peptide ( Fig. 1 ). We chose 2,4-diaminobutanoic acid (Dab) to replace the acceptor asparagine, because Dab-containing peptides were previously shown to act as competitive inhibitors of bacterial and eukaryotic OSTs at physiological pH ( Fig. 1A) 21, 25, 26 . We investigated whether the Dab-containing peptide and the functional LLOs showed activity with PglB at pH values used to crystallize it (pH ~8.9) and did not detect any glycosylation of the Dab-containing peptide, demonstrating that no glycan transfer occurs even after very long incubations. We therefore used this Dab-containing peptide for crystallization experiments. We used the reactive synthetic LLO analog ωZZZ-PP-GlcNAc, which is chemically very similar to the wild type LLO except that it contains a GlcNAc rather than di-Nacetyl-bacillosamine as a reducing-end sugar ( Fig. 1) 19 . This LLO compound exhibited the highest turnover rate of all of the water-soluble synthetic LLO analogs tested 19, 27 . The resulting ternary complex was crystallized and the structure determined at 3.4 Å resolution ( Fig. 2 and Table 1 ).
LLO binding and the role of Mn 2+ . Whereas the overall structure of PglB bound to the reactive LLO and inhibitory peptide is very similar to the previously determined ternary complex, there are important differences ( Fig. 2, Supplementary Fig. 1 ) 19 . The key difference is that the two substrates are closer in the new ternary complex, with a distance of ~3.4 Å between carbon C-1 of the GlcNAc moiety of reactive LLO and the -NH 2 group of the Dab residue, representative of the atoms that would form an N-glycosidic bond if Dab was replaced by Asn. In contrast, the equivalent distance between the GlcNAc of non-reactive LLO and the acceptor asparagine was ~6 Å in the previously determined structure 19 . The closing of the distance is mainly due to a shift of the reducing-end GlcNAc and is probably due to new contacts formed. Whereas the lipid tail of the LLO analog has an indistinguishable conformation to the previous ternary complex, the pyrophosphate and GlcNAc moieties have shifted and interact differently with the surface of PglB in the new structure ( Fig. 3 ). We now observe continuous electron density between the pyrophosphate group of LLO and the catalytic Mn 2+ , with the shortest distance (~4 Å) observed between Mn 2+ and the oxygen linking C1 of GlcNAc and the pyrophosphate moiety ( Fig. 3A , Supplementary Fig. 2 ). This indicates that the divalent metal ion, instead of being coordinated by water molecules, interacts with the pyrophosphate group. The structure also revealed different interactions between the pyrophosphate of the LLO and two essential catalytic residues, R375 and Y196. They appear to form hydrogen bonds with both phosphate groups, not just with the phosphate directly attached to the GlcNAc, as was observed for the ternary complex with non-reactive LLO (Fig. 3 ). This may explain why mutation of either of these residues to alanine abolished the glycosylation activity of PglB, but not binding of acceptor peptide 19, 22 . Our structure also revealed contacts between the reducing-end sugar and PglB that were not observed before. In the previous ternary complex, the N-acetyl group of the reducing-end GlcNAc was at a distance of ~3.1 Å from Y468 but was not close enough to interact with D56 (distance of 5.2 Å). In the present structure, the N-acetyl group can form hydrogen bonds with the side chains of both D56 and Y468. The carbonyl oxygen is placed at a distance of 2.2 Å from the hydroxyl oxygen of Y468, whereas the nitrogen is at a distance of 3.3 Å from the carboxyl group of D56. Both D56 and Y468 have previously been demonstrated to be essential for PglB activity, but D56 was only shown to be involved in Mn 2+ coordination and peptide binding 14, 19 . Because both D56 and Y468 are strictly conserved catalytic residues, the newly identified interactions are likely relevant for all OST enzymes.
Mobility of the reducing-end GlcNAc in the catalytic site. The electron density for the lipid tail and the pyrophosphate group of reactive LLO was stronger than that for the GlcNAc moiety, unlike in the previous ternary complex with non-reactive LLO where the quality of the density for the LLO was similar throughout 19 . This suggests that either the sugar moiety of the reactive LLO molecule is more mobile, or that the LLO may have been hydrolyzed in the crystallization conditions, which would result in a mixture of LLO and lipid-pyrophosphate. Both PglB and yeast octameric OST were previously reported to exhibit hydrolytic activity and produce free oligosaccharides (fOS) in the absence of the acceptor sequon [28] [29] [30] . We therefore tested the stability of LLO by incubating it in crystallization conditions in the presence of PglB and the presence or absence of Dab peptide. We then quantified the amount of LLO left using an in vitro glycosylation assay, where the samples were diluted and incubated with freshly purified PglB and an excess of fluorescently labeled wild type peptide over LLO ( Fig. 4A ) 19, 21, 22 .
We did not detect any loss of LLO in the crystallization conditions over a period of 48 hours, which suggests that the intact LLO analog, and not its hydrolyzed derivative, are present in the co-crystal (Fig. 4B ). The discrepancy between our results from in vitro experiments and previous studies remains unresolved 28, 29 . Because there is no LLO hydrolysis in our experiment, the slightly weaker density for GlcNAc could be explained by an increased mobility of the GlcNAc moiety of the reactive LLO. We speculate that for wild type heptasacccharide-containing LLO the presence of extra sugar moieties would form additional interactions with PglB, likely decreasing the mobility of the reducing-end sugar. Binding of the inhibitory peptide. The position of the backbone of the inhibitory peptide is unaltered relative to that of the wild type peptide in the previous ternary complex, validating the use of the Dab-containing peptide as a substrate mimic 19 . The Dab side chain reaches the catalytic site where it can form hydrogen bonds with three conserved and catalytically essential residues, the side chains of D56 and E319 and the main chain carbonyl oxygen of G482 ( Fig. 3 and Supplementary Fig. 2 ) 14, 21, 22, 31 . It was previously shown that replacing the acceptor asparagine with Dab resulted in a 10-fold decrease in peptide affinity 21 . This suggests that the presence of the carbonyl oxygen in the acceptor asparagine side chain, and the absence of a charge on the -NH 2 group, produce favourable interactions with the enzyme that contribute to the binding affinity but also allow glycan transfer. However, when comparing the Dab-peptide-to the wild type-peptide-bound structure of PglB, there are no specific interactions (hydrogen bonds) between PglB and the carbonyl group of the acceptor asparagine that would contribute significantly to the increased peptide affinity, as only van der Waals interactions are observed ( Fig. 3B) 19 . The exact chemical mechanism of increased binding and transfer activity, and the precise reason for why Dab is inhibiting, are therefore unknown.
Discussion
The ternary complex presented here provides a first structural view into how OST interacts with a reactive LLO molecule. The captured intermediate is closer to the transition state of the glycosylation reaction than the previous ternary complex, because we observe an interaction between the pyrophosphate group of LLO and the Mn 2+ ion, and the C-1 of GlcNAc is closer to the Dab side chain of the peptide than to the amide nitrogen in the previous structure 19 . The new structure also provides direct evidence that one of the roles of the divalent metal ion is the stabilization of the pyrophosphate, the leaving group of the substitution reaction. Similar roles were attributed to divalent metal ions in other glycosyltransferases (GTs) and were expected/predicted for OST 22, [32] [33] [34] [35] . Unexpectedly, however, the Mn 2+ ion seems to be coordinated by the glycosidic oxygen atom rather than the negatively charged phosphate oxygens as observed in structures of GT-A superfamily members 32 . This suggests that the divalent metal ion might directly activate the glycosidic oxygen during the reaction by generating a reactive electrophile. This could compensate for the poor nucleophilicity of the carboxamide group of the acceptor asparagine and might even allow glycan transfer without amide activation. This hypothesis is in line with the observed inhibitory effect of Dab-containing peptides that cannot be glycosylated in vitro, which is probably due to the absence of a free electron pair in the protonated form. In contrast, it has been shown that a homoserine-containing peptide, which has the same number of methylene groups and therefore the same side chain length as Dab, is O-glycosylated 21 . The hydroxyl group of the homoserine analog, unlike the protonated Dab side chain, readily provides free electron pairs that can act as a nucleophile during the substitution reaction. An N-acetyl group at the C-2 position of the reducing-end sugar is highly favoured by PglB and is strictly required for glycan transfer in eukaryotic OSTs 1, 11, 12, 15, 36, 37 . Biochemical studies of yeast OST showed that minor modifications to this substituent, such as replacement of hydrogens with fluorines, reduced LLO binding and abolished glycosylation activity probably because the electron-withdrawing trifluoromethyl group made the neighbouring carbonyl oxygen a less efficient hydrogen bond acceptor 16 . The new ternary complex of PglB reveals hydrogen bonding interactions between the N-acetyl group of LLO and residues D56 and Y468 in the catalytic site of PglB. Because D56 also interacts with the acceptor peptide and the bound divalent metal ion, modification of the N-acetyl substituent is likely to affect the entire hydrogen bonding network, impairing glycan transfer 16 . Although the new ternary complex reveals novel interactions, future functional and molecular dynamics studies are required to give insight into the exact role of the divalent metal ion in activation of the glycosidic oxygen of LLO. The recent cryo-EM structures of eukaryotic octameric OSTs revealed that the fold and key side chains of the catalytic STT3 subunit are conserved, demonstrating that PglB is an excellent model system to study the glycosylation reaction 19, [37] [38] [39] . The structure presented here is therefore likely to prove valuable for future mechanistic interpretations not only of bacterial ssOSTs, but of OSTs from all domains of life.
Materials and Methods
Overexpression and purification of PglB. Overexpression and purification of PglB was performed as previously described 19 . Briefly, PglB was overexpressed in Escherichia coli BL21-Gold cells (DE3) (Strategene) at 37 °C in five-liter flasks using Terrific Broth medium supplemented with 1% glycerol (w/v). The cells were induced at 37 °C for 4 h at A600 of 3.0 by adding 0.1% arabinose (w/v). All following steps were carried out at 4 °C. Cells were harvested by centrifugation. Cells were resuspended in 25 mM Tris-HCl, pH 8.0, 250 mM NaCl and disrupted in a M-110-l microfluidizer (Microfluidics) at 15,000 p.s.i. chamber pressure. Membranes were pelleted by centrifugation at 100,000 g for 30 min and solubilized in 25 mM Tris-HCl, pH 8.0, 250 mM NaCl, 10% glycerol (v/v) and 1% N-dodecyl-β-D-maltopyranoside (w/v) (DDM, Anatrace) for 1.5 h. All subsequent purification buffers contained 0.016% DDM. PglB was purified on a nickel-nitrilotriacetic acid (Ni-NTA) Superflow affinity column (Qiagen) and desalted into 10 mM MES, pH 6.5, 100 mM NaCl, 3% glycerol (v/v), and 0.016% DDM. For crystallization experiments, desalted protein was concentrated to 6 mg mL −1 in an Amicon Ultra-15 concentrator (Milipore) with a molecular mass cutoff of 100 kDa and purified by size exclusion chromatography (Superdex 200 10/300, GE Healthcare) in desalting buffer. Collected fractions were pooled and concentrated to 12 mg mL −1 .
Protein crystallization. Ac-DQ(Dab)ATF(p-NO 2 )-NH2, nerylneryl-PP-GlcNAc and MnCl 2 were added to the concentrated protein to the final concentration of 0.75 mM, 1.5 mM, 2 mM, respectively and incubated for 15 min at 4 °C. PglB was crystallized by vapor diffusion in hanging drops at 20 °C against a reservoir containing 100 mM glycine, pH 9.4, 50-200 mM magnesium acetate, and 27-31% PEG400 at the protein-to-reservoir ratio 2:1. Crystals usually appeared after 10-14 days and grew to full size within 3-4 weeks. Crystals were cryoprotected by stepwise addition of cryoprotectant PEG400 up to 30% final concentration and directly flash frozen in liquid nitrogen before data collection.
Data collection and structural determination. The X-ray data was collected at the microfocus X06SA beamline at the Swiss Light Source (Villigen). The wavelength for data collection was 1.000 Å. All data were processed using XDS package 40 . Ellipsoidal truncation and anisotropic correction were applied to the data using the diffraction anisotropy server 41 . The ternary complex crystallized in the P2 1 2 1 2 1 space group, containing one PglB molecule per asymmetric unit. The structure was solved by molecular replacement using PDB 5OGL as a model. The iterative model building and refinement was performed in Coot 42 and Phenix 43 . Final refinement statistics and data collection are summarized in Table 1 . Structural figures were drawn using PyMOL 44 .
Quantification assay. LLO and PglB were incubated in the presence or absence of Dab peptide for 48 h at 20 °C. The mixture conditions replicated the crystallization conditions, where 10 mg mL −1 PglB, 1.5 mM LLO (nerylneryl-PP-GlcNAc), 0.75 mM inhibitory peptide (Ac-DQ(Dab)ATF{p-NO2}-NH2) in 10 mM MES pH 6.5, 3% glycerol, 100 mM NaCl, 0.016% DDM was added to 100 mM glycine pH 9.4, 28% PEG 400, 200 mM magnesium acetate in 2:1 ratio. The samples were diluted and the LLO was quantified against fluorescently labeled wild type peptide (DQNATF). The LLO dilutions were incubated for 12 h at 25 °C with 10 µM labeled peptide and purified protein in reaction buffer containing 10 mM MES pH 6.5, 100 mM NaCl, 3% glycerol 0.016% DDM, 10 mM MnCl 2 . The samples were analyzed by in-gel fluorescence and the ratio between glycosylated and non-glycosylated peptide was calculated using ImageJ. The concentration of LLO was determined in reactions where the wild type peptide was always present in excess over LLO. Data was fitted by linear regression in GraphPad PRISM 7.0.
Synthesis of nerylneryl-PP-GlcNAc ((ωZZZ)-PP-GlcNAc)
). The nerylneryl-PP-GlcNAc ((ωZZZ)-PP-GlcNAc) analog was synthesized according to previously reported procedures 19, 27 . The synthetic strategy included three steps: the synthesis of GlcNAc α-phosphate, preparation of the nerylneryl-phosphate precursor, and finally the coupling of both monophosphates to the desired final pyrophosphate. Nerylneryl-PP-GlcNAc was shown to be pure by 1 H, 13 C, 31 P NMR and ESI-HRMS.
